Compound ID | 2721
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | RNA synthesis inhibitor. Binds to RNA polymerase |
| Target Pathogen: | Active against multidrug-resistant and -susceptible Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus viridans |
| Description: | Natural product from Streptomyces achromogenes var. rubradiris; ansamycin-type |
| Institute where first reported: | The Upjohn Company, MI USA |
| Year first mentioned: | 1965 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54711001 |
| Citations: |
|